openPR Logo
Press release

US Rosacea Market 2018 Analysis by Key Players & Industry Size

10-23-2018 12:41 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: MarketReportsOnline

US Rosacea Market Analysis

US Rosacea Market Analysis

Scope of Rosacea Market Report:

This research report “The US Rosacea Market: Size, Trends & Forecasts (20018-2022)” http://www.marketreportsonline.com/732043.html. provides a detailed analysis of the US rosacea market with market sizing and growth pattern. The analysis includes rosacea market in terms of value, number of patients; number of patients seeking treatment and market share by segments. It also provides analysis of the US dermatology drugs market in terms of value and market share by segments.

Furthermore, the report also assesses the key opportunities available in the market and summarizes the dynamic forces that are and will be accountable for growth of the industry. Growth of the US rosacea market has also been forecasted for the period 2018-2022, taking into consideration previous growth outlines, growth drivers and the existing and forthcoming trends.

Foamix Pharmaceuticals Ltd., Bayer Group, Galderma and Valeant Pharmaceuticals International are some of the major players whose company profiling has been done in the report. This segment of the report summarizes business overview, financial overview and the business strategies adopted by respective companies.

Purchase a copy of this report @ http://www.marketreportsonline.com/contacts/purchase.php?name=732043.

Company Coverage: Foamix Pharmaceuticals Ltd., Bayer Group, Galderma & Valeant Pharmaceuticals International

Rosacea is a common chronic condition of the skin with a high prevalence rate among the US population. It is observed that it naturally begins at any time after the age of 30 and more and mostly affect the area of nose, cheeks and forehead. In some cases, rosacea may also occur on the neck, chest, scalp or ears. Rosacea symptoms and signs include facial flushing, fine red vascular lines, swollen, red eyelids and many more. The disease is more common in women and those who have fair skin. The cause of such skin condition is still unknown and cannot be cured. The only way to control rosacea is by minimizing its symptoms.

The US rosacea market has grown over the past few years and is anticipated to grow during the forecasted period also i.e. 2018-2022 at a high growth rate on the back of rising incidence rate of the disease among the US population.

Access Full Report @ http://www.marketreportsonline.com/732043.html.

The growth in the market will be driven by aging population, unhealthy eating habits and environmental factors, rising disposable income and entry of new drugs and treatments in the market. Yet the market growth is restrained by factors such as lack of awareness and knowledge and stringent government regulations for the approval of new drugs.

Few Points from List of Tables & Figures Provided in US Rosacea Market:

Table 1: The US Rosacea Market Top Brands by Value; 2016

Table 2: The US Rosacea Market Top Brands by Volume; 2016

Table 3: The US Rosacea Drugs Competitive Landscape

Table 4: Product Candidate Pipeline

Table 5: Finacea (FMX103) related Events (Completed and Anticipated)

Figure 1: Types of Rosacea

Figure 2: The US Dermatology Drugs Market by Value; 2014-2017 (US$ Billion)

Figure 3: The US Dermatology Drugs Market by Value; 2018-2022E (US$ Billion)

Figure 4: The US Dermatology Drugs Market by Segments; 2016

Figure 5: The US Rosacea Market by Value; 2016-2017 (US$ Billion)

Figure 6: The US Rosacea Market by Value; 2018-2022E (US$ Billion)

Figure 7: The US Rosacea Market by Number of Patients; 2016-2017 (Million)

Figure 8: The US Rosacea Market by Number of Patients; 2018-2022E (Million)

Figure 9: The US Rosacea Market by Number of Patients Seeking Treatment;2017-2022E (Million)

Figure 10: The US Rosacea Market by Segments; 2016

Figure 11: Share of Old Age Population (65 years and Older) in the Total US Population; 1990-2020 (%)

Figure 12: The US Disposable Personal Income; 2013-2017 (US$ Trillion)

Figure 13: The US Rosacea Market by Players/Drugs; 2016

Figure 14: Foamix Pharmaceuticals Ltd. Revenues; 2012-2016 (US$ Million)

Figure 15: Bayer Group Revenues; 2012-2016 (US$ Billion)

Browse all latest pharmaceuticals market research reports @ http://www.marketreportsonline.com/cat/pharmaceuticals-market-research.html.

About Us:
Market Reports Online is a comprehensive online library of more than 100,000 reports, in-depth market research studies on thousands of micro markets and a range of industries. The reports are analytically and statistically rich, and offer a comprehensive view of the dynamic market scenario across the globe. We offer online and offline support services to ensure your research requirements are met on time.

Contact Info:
Hrishikesh Patwardhan
Tel: 1 888 391 5441
Email: sales@marketreportsonline.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release US Rosacea Market 2018 Analysis by Key Players & Industry Size here

News-ID: 1321652 • Views:

More Releases from MarketReportsOnline

US Lettuce & Chicory Market Key Players, Exports & Imports, Size, Share, Demands …
The US lettuce and chicory market is forecasted to reach US$5.09 billion in 2026, experiencing growth at a CAGR of 2.62% during the period spanning from 2022 to 2026. Growth in the lettuce and chicory market is supported by factors such as rising population, rising middle class spending, shift towards veganism/ vegetarianism, increasing awareness regarding the health benefit of chicory and rising social media influence. However, the market growth is
Global Breast Biopsy Market - Hologic, Danaher Corporation, Becton, Dickinson & …
The global breast biopsy market is forecasted to reach US$1.75 billion in 2025, experiencing growth at a CAGR of 8.56% for the period spanning 2022-202. Growth in the global breast biopsy market was supported by factors such as increasing prevalence of breast cancer and rising female population aged 65 or above. Growing adoption of liquid biopsy is likely to have a positive impact on the global breast biopsy market. However,
Global Contract Development & Manufacturing Organization Market - Catalent, Inc. …
The global Contract Development & Manufacturing Organization (CDMO) market is estimated to reach US$246.6 billion in 2026, growing at a CAGR of 9.31%, for the period spanning 2022-2026. The factors such as increasing per capita disposable income, increasing global healthcare expenditure, rising aging population, increasing R&D spending, growing number of new drugs, rise in investments and strategic collaborations and growing demand for pharmaceutical products are expected to drive the market.
Korean Gaming Market (Mobile, PC and Console) - Netmarble, Pearl Abyss, NCSoft, …
The Korean gaming market is anticipated to reach US$20.98 billion in 2026, growing at a CAGR of 6.21% during the period spanning 2022-2026. After the U.S., China, and Japan, it is the fourth largest market, accounting for more than 6% of the worldwide gaming industry in 2021. The growth in the market has been driven by factors like rising smartphone penetration, rapid urbanization, rising gaming subscribers' penetration rate, expansion of MMORPGs,

All 5 Releases


More Releases for Rosacea

The Rosacea Treatment Market to sail through predictive analysis
The Rosacea Treatment Market is expected to grow on a healthy note further. The current scenario is such that virtual monitoring tools are being called for. They act as a precision factor for the healthcare vertical. With the turning out to be more accessible for patients and providers alike, several post-operative intervention options are being made available for preventing hospital re-admittance and complications. With cost-effectiveness rendered as well, the healthcare
Acne & Rosacea Market Analysis Forecast Report 2022 – MarketReportsOnline
MarketReportsOnline.com adds "US Acne & Rosacea Market: Industry Analysis & Outlook (2018-2022)" report to its research store. The report “U.S. Acne & Rosacea Market: Industry Analysis & Outlook (2018-2022)” provides an extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers and challenges of the market, covering the U.S. market. The report profiles the key players of the market including Bausch
Rosacea Treatment Market Report 2018: Segmentation by Product (Topical therapy, …
Global Rosacea Treatment market research report provides company profile for Allergan, Dermik Laboratories Inc, Merz Pharma GmbH & Co. KGaA, Galderma, Valeant Pharmaceuticals, Bayer, Mayne Pharma and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025,
Rosacea Therapeutics Market Overview and forecasts to 2024
Rosacea Therapeutics Market: Overview The American Academy of Dermatology states that over 14 million people are currently living with rosacea in the U.S. alone. The Canadian Dermatology Association reports that this chronic skin condition affects over two million people in the country, while the British Skin Foundation finds that more than eight million people in the U.K. suffer from various skin conditions, including rosacea. The rising incidence of this skin disease
Rosacea Therapeutics Market Trends and Prospects by 2024
Rosacea Therapeutics Market: Overview The American Academy of Dermatology states that over 14 million people are currently living with rosacea in the U.S. alone. The Canadian Dermatology Association reports that this chronic skin condition affects over two million people in the country, while the British Skin Foundation finds that more than eight million people in the U.K. suffer from various skin conditions, including rosacea. The rising incidence of this skin disease
Rosacea Therapeutics Market Analysis, Growth & Forecast 2024
Rosacea Therapeutics Market: Overview   The American Academy of Dermatology states that over 14 million people are currently living with rosacea in the U.S. alone. The Canadian Dermatology Association reports that this chronic skin condition affects over two million people in the country, while the British Skin Foundation finds that more than eight million people in the U.K. suffer from various skin conditions, including rosacea. The rising incidence of this skin